EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fluorinated and N-Acryloyl-Modified 3,5-Di[(E)-benzylidene]piperidin-4-one Curcuminoids for the Treatment of Pancreatic Carcinoma

Hindole Ghosh, Sangita Bhattacharyya, Rainer Schobert iD, Prasad Dandawate iD, Bernhard Biersack iD

Pharmaceutics · 11.07.2023 · 15 (7) · 1921

DOI: 10.3390/pharmaceutics15071921 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 11.07.2023. Verfasst von Hindole Ghosh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic carcinoma is a cancer disease with high mortality. Thus, new and efficient treatments for this disease are badly needed. Curcumin has previously shown promising effects in pancreatic cancer patients; however, this natural compound suffers from inadequate efficacy and bioavailability, preventing its clinical approval. The synthetic curcuminoid EF24 was developed with activities superior to curcumin against various cancer types. In this study, a series of analogs of EF24 were investigated for anticancer effects on pancreatic carcinoma models. A distinct activity boost was achieved by straightforward N-acrylation of EF24 analogs, in particular, of compounds bearing 3-fluoro-4-methoxybenzylidene, 3,4-difluorobenzylidene, and 4-trifluoromethylbenzylidene moieties, while no improvement was seen for N-acryloyl-modified EF24. Apoptosis induction and suppression of phospho-STAT3 levels were determined, the latter corroborated by docking of active curcuminoids into STAT3. Hence, promising new clues for the development of efficient and superior curcuminoids as valuable treatment options for one of the most lethal cancer diseases were discovered in this study.

Schlagwörter

Stichwörter der Autor:innen

EF24acryl amideanticancer agentscurcuminpancreatic carcinoma

Autor:innen und Institutionen

  • Cancer Biology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA.
  • Organic Chemistry 1, University of Bayreuth, Universitaetsstrasse 30, 95440 Bayreuth, Germany.

ORCID-Profile: Rainer Schobert, Prasad Dandawate, Bernhard Biersack

Zitieren

APA

Ghosh, H., Bhattacharyya, S., Schobert, R., Dandawate, P., & Biersack, B. (2023). Fluorinated and N-Acryloyl-Modified 3,5-Di[(E)-benzylidene]piperidin-4-one Curcuminoids for the Treatment of Pancreatic Carcinoma. Pharmaceutics, 15(7), 1921. https://doi.org/10.3390/pharmaceutics15071921

Vancouver

Ghosh H, Bhattacharyya S, Schobert R, Dandawate P, Biersack B. Fluorinated and N-Acryloyl-Modified 3,5-Di[(E)-benzylidene]piperidin-4-one Curcuminoids for the Treatment of Pancreatic Carcinoma. Pharmaceutics. 2023;15(7):1921. doi:10.3390/pharmaceutics15071921

BibTeX
@article{Ghosh2023,
  author = {Ghosh, Hindole and Bhattacharyya, Sangita and Schobert, Rainer and Dandawate, Prasad and Biersack, Bernhard},
  title = {Fluorinated and N-Acryloyl-Modified 3,5-Di[(E)-benzylidene]piperidin-4-one Curcuminoids for the Treatment of Pancreatic Carcinoma},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {7},
  pages = {1921},
  doi = {10.3390/pharmaceutics15071921}
}
Kostenlos starten →